Ensitrelvir, an oral SARS-CoV-2 3C-like protease inhibitor, reduced symptomatic RT-PCR-confirmed COVID-19 among household ...

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

A new study led by researchers at the University of Malaga proposes a new antiviral strategy against SARS-CoV-2—the virus ...

BA.3.2 spread internationally after first being identified in South Africa in November 2024, with detections rising from September 2025 and reports from at least 23 countries by 11 February 2026. U.S.

A pill called ensitrelvir is the first drug shown to effectively reduce infection after exposure to SARS-CoV-2.

Scientists have identified new bat coronaviruses, closely related to SARS-CoV-2, capable of infecting human cells. These ...

The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...

A new variant of the SARS-CoV-2 virus, dubbed Cicada, is less susceptible to vaccination and appears to discriminate based on ...

Herd immunity has already developed worldwide.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The BA.3.2 COVID-19 variant was first detected in South Africa in November 2024 but has ...